Analytical Data
-
基因名
MGC3101
- Application
-
别名
Dysbindin domain-containing protein 1
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
D3DX86
-
表达区间
1-156 aa
-
氨基酸序列
MAGLPIPPEIVKEAEVPQAALGVPAQGTGDNGHTPVEEEVGGIPVPAPGLLQVTERRQPLSSVSSLEVHFDLLDLTELTDMSDQELAEVFADSDDENLNTESPAGLHPLPRAGYLRSPSWTRTRAEQSHEKQPLGDPERQATVLDTFLTVERPQED
-
分子量
43.3 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MGC3101 is a recombinant protein that has garnered attention in the field of molecular biology and biotechnology due to its potential applications in various therapeutic areas. Initially identified as a candidate for enhanced immunological responses, the MGC3101 protein has been studied for its role in modulating immune pathways, offering insights into the mechanisms underlying immune regulation. The recombinant expression systems used to produce MGC3101 facilitate large-scale production and simplify purification processes, making it a valuable tool for both basic research and clinical applications. Moreover, studies have indicated that MGC3101 may play a crucial role in the development of vaccines and therapeutic agents for infectious diseases and autoimmune disorders. As researchers continue to unravel its functional characteristics and interactions at the molecular level, MGC3101 stands poised to contribute to innovative therapeutic strategies, highlighting the significance of recombinant proteins in modern medicine.
